-
Mashup Score: 1
An official on the administration’s antisemitism task force told the university that a letter of demands had been sent without authorization.
Source: www.nytimes.comCategories: General Medicine NewsTweet
-
Mashup Score: 4What happened to pathology AI companies? - 1 month(s) ago
4k words, 19 minutes reading time
Source: www.owlposting.comCategories: General Medicine NewsTweet-
RT @tangming2005: Fascinating read: What happened to pathology AI companies? https://t.co/1A6kk6DkDw https://t.co/IVP1VTllx6
-
-
Mashup Score: 0FDA Safety Announcement - 3 month(s) ago
The FDA is providing this communication to increase awareness of recent updates to the product labeling of capecitabine and fluorouracil (5-FU).
Source: www.fda.govCategories: General Medicine News, Hem/OncsTweet-
Important safety milestone https://t.co/P83l1XZ77n
-
-
Mashup Score: 12Overcoming Therapeutic Resistance in HER2-Positive Breast Cancers with CDK4/6 Inhibitors - PubMed - 5 month(s) ago
Using transgenic mouse models, cell line-based functional studies, and clinical specimens, we show that cyclin D1/CDK4 mediate resistance to targeted therapy for HER2-positive breast cancer. This is overcome using CDK4/6 inhibitors. Inhibition of CDK4/6 not only suppresses Rb phosphorylation, but al …
Source: pubmed.ncbi.nlm.nih.govCategories: General Medicine News, Hem/OncsTweet-
What a great example of 🧪➡️💉research @DFCI_BreastOnc @Otto_DFCI . @shomgoel Jean Zhao first reported preclinical evidence of efficacy for CDK4/6i in HER2+ BC: https://t.co/cOrSFBA5BA https://t.co/2Nqv7hoFSO
-
-
Mashup Score: 1ClinicalTrials.gov - 5 month(s) ago
Hide glossary Study record managers: refer to the Data Element Definitions if submitting registration or results information.
Source: clinicaltrials.govCategories: General Medicine News, Hem/OncsTweet-
@DrHBurstein Wonder if ALPHABET will add PIK3Ca⛔️to this strategy? https://t.co/JJ0Ra5afXk
-
-
Mashup Score: 4
Nature – AKT inhibitors synergize with agents that suppress the histone methyltransferase EZH2 and promote robust tumour regression in multiple triple-negative breast cancer models in vivo by…
Source: www.nature.comCategories: General Medicine News, Hem/OncsTweet-
AKT and EZH2 inhibitors kill TNBCs by hijacking mechanisms of involution | Nature https://t.co/w6siv7Qi6i
-
-
Mashup Score: 12Physician-Scientist to Research-Engaged Physician - 8 month(s) ago
Physicians engaged in research represent the promise of a better future—more effective treatments, better strategies for diagnosis and prevention, and long sought-after cures. Driven by curiosity, physician-scientists take observations from the clinical setting, infuse their current understanding of…
Source: jamanetwork.comCategories: General Medicine News, Hem/OncsTweet-
RT @jmvyasmdphd: Physician-Scientist to Research-Engaged Physician https://t.co/ww74jHepAu Happy to share our editorial on physician-scie…
-
-
Mashup Score: 12Physician-Scientist to Research-Engaged Physician - 8 month(s) ago
Physicians engaged in research represent the promise of a better future—more effective treatments, better strategies for diagnosis and prevention, and long sought-after cures. Driven by curiosity, physician-scientists take observations from the clinical setting, infuse their current understanding of…
Source: jamanetwork.comCategories: General Medicine News, Hem/OncsTweet-
RT @jmvyasmdphd: Physician-Scientist to Research-Engaged Physician https://t.co/ww74jHepAu Happy to share our editorial on physician-scie…
-
-
Mashup Score: 69RINGS OF POWER - Old Tom Bombadil | Cover by Rachel Hardy - 8 month(s) ago
Rings of Power Season 2 is out, and I have sure been enjoying the music so far! I was so pleased to hear Tom Bombadil’s Song brought to life by Rings of Powe…
Source: www.youtube.comCategories: General Medicine News, Hem/OncsTweet-
RT @bearmccreary: An absolutely gorgeous cover of “Old Tom Bombadil.” Thank you (@RachelHardy306!) https://t.co/YlmIi8ETue
-
-
Mashup Score: 0Dana-Farber CEO Laurie Glimcher to step down, saying ‘we must look to the next generation’ - The Boston Globe - 9 month(s) ago
Starting Oct. 1, the famed cancer institute will be led by Benjamin Ebert, chair of its medical oncology department.
Source: www.bostonglobe.comCategories: General Medicine News, Hem/OncsTweet-
https://t.co/PmD7mmZhDC
-
“That [America] that was wont to conquer others Hath made a shameful conquest of itself.” https://t.co/xaGvBff2Bw via @NYTimes